9 results match your criteria: "Nihonbashi Muromachi Mitsui Tower Midtown Clinic[Affiliation]"

Real-time visualization of red blood cell flow inside subepithelial microvessels is performed with magnifying endoscopy. However, microvascular blood flow velocity in the colorectum has not been investigated. Here, we aimed to evaluate the blood flow velocity of microvessels of colonic polyps and to compare it with that of surrounding mucosa.

View Article and Find Full Text PDF

Olympus Corporation developed texture and color enhancement imaging (TXI) as a novel image-enhancing endoscopic technique. This topic highlights a series of hot-topic articles that investigated the efficacy of TXI for gastrointestinal disease identification in the clinical setting. A randomized controlled trial demonstrated improvements in the colorectal adenoma detection rate (ADR) and the mean number of adenomas per procedure (MAP) of TXI compared with those of white-light imaging (WLI) observation (58.

View Article and Find Full Text PDF

Data were collected to establish a reference interval for glycated albumin (GA), as well as to calculate a cutoff value for diagnosing diabetes mellitus and the GA level corresponding to a 75-g oral glucose tolerance test (OGTT) 2 h plasma glucose (2h-PG) level of 200 mg/dL. This study involved 1,843 subjects who were undergoing medical check-ups at several medical institutions and whose HbA1c and GA levels had been measured by OGTT. The GA reference interval that was calculated based on the data obtained from study subjects with normal glucose tolerance was 12.

View Article and Find Full Text PDF
Article Synopsis
  • A study evaluated postoperative anastomotic lesions in Crohn's disease (CD) patients who underwent intestinal resection, finding that these lesions commonly recur within a year.
  • Researchers analyzed data from 267 patients and noted that the severity and prevalence of these lesions increased over time, leading to more interventions for those with more severe lesions.
  • The findings suggest that intermediate and severe lesions might indicate recurrent disease, while mild lesions may not, highlighting the need for further prospective studies to improve treatment approaches.
View Article and Find Full Text PDF

The genetic risk factors for anastomotic recurrence (AR) after curative surgery for colorectal cancer (CRC) are unclear. The present study is a single-center retrospective observational study that aimed to elucidate the association between the mutation and AR in CRC. The present study included 21 patients with AR and 67 patients with non-anastomotic local recurrence (NALR) following curative surgery for CRC between January 2005 and December 2019.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the risk factors for anastomotic recurrence in colorectal cancer and compares its prognosis with nonanastomatic local recurrence, using data from 1,584 patients who underwent surgery from 2005 to 2017.
  • Results show that anastomotic recurrence occurred in 0.95% of patients, with risk factors being lymph node metastasis and advanced T stage, but prognosis was similar to nonanastomotic cases.
  • Limitations include the small sample size of patients with anastomotic recurrence and potential biases due to the study's retrospective nature.
View Article and Find Full Text PDF

Although untreated Graves' disease (GD) is associated with a higher risk of cardiac complications and mortality, there is no well-established way to predict the onset of thyrotoxicosis in clinical practice. The aim of this study was to identify important variables that will make it possible to predict GD and thyrotoxicosis (GD + painless thyroiditis (PT)) by using a machine-learning-based model based on complete blood count and standard biochemistry profile data. We identified 19,335 newly diagnosed GD patients, 3,267 PT patients, and 4,159 subjects without any thyroid disease.

View Article and Find Full Text PDF

Many clinical trials have been conducted for inflammatory bowel disease (IBD), so various clinical indices (CIs) and endoscopic indices (EIs) have also been evaluated. However, recently, with the progress of IBD management, review of established indices from previous studies, and establishment of new indices, the landscape of the use of indices in clinical trials have changed. We investigated the number and frequency of the indices adapted in recent clinical trials for ulcerative colitis (CI and EI) and Crohn's disease (CI, EI, index related to magnetic resonance imaging, index for evaluating patient-reported outcomes, and health-related quality of life).

View Article and Find Full Text PDF